Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue

The delivery of safe, visible wavelengths of light can be an effective, pathogen-agnostic, countermeasure that would expand the current portfolio of SARS-CoV-2 intervention strategies beyond the conventional approaches of vaccine, antibody, and antiviral therapeutics. Employing custom biological lig...

Descripción completa

Detalles Bibliográficos
Autores principales: Stasko, Nathan, Kocher, Jacob F., Annas, Abigail, Henson, Ibrahim, Seitz, Theresa S., Miller, Joy M., Arwood, Leslee, Roberts, Rachel C., Womble, Thomas M., Keller, Emily G., Emerson, Soren, Bergmann, Michael, Sheesley, Ashley N. Y., Strong, Rebecca J., Hurst, Brett L., Emerson, David, Tarbet, E. Bart, Bradrick, Shelton S., Cockrell, Adam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523529/
https://www.ncbi.nlm.nih.gov/pubmed/34663881
http://dx.doi.org/10.1038/s41598-021-99917-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523529/
https://www.ncbi.nlm.nih.gov/pubmed/34663881
http://dx.doi.org/10.1038/s41598-021-99917-2

Ejemplares similares